Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free VHI Stock Alerts

Vitalhub (VHI) Competitors

Vitalhub logo
C$7.90 -0.11 (-1.37%)
As of 04:00 PM Eastern
Compare

VHI vs. CARE, RHT, ADK, DOC, and ZMD

Should you buy Vitalhub stock or one of its competitors? Vitalhub's main competitors and comparable companies include Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), CloudMD Software & Services (DOC), and ZoomMed (ZMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Vitalhub compare to Dialogue Health Technologies?

Vitalhub (TSE:VHI) and Dialogue Health Technologies (TSE:CARE) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Vitalhub has higher revenue and earnings than Dialogue Health Technologies. Dialogue Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$127.08M3.93C$3.35MC$0.1265.83
Dialogue Health TechnologiesC$95.88M0.00-C$19.50M-C$0.30N/A

Vitalhub has a beta of 0.914183, suggesting that its share price is 9% less volatile than the broader market. Comparatively, Dialogue Health Technologies has a beta of 2.66, suggesting that its share price is 166% more volatile than the broader market.

In the previous week, Vitalhub had 3 more articles in the media than Dialogue Health Technologies. MarketBeat recorded 3 mentions for Vitalhub and 0 mentions for Dialogue Health Technologies. Vitalhub's average media sentiment score of 0.00 equaled Dialogue Health Technologies'average media sentiment score.

Company Overall Sentiment
Vitalhub Neutral
Dialogue Health Technologies Neutral

25.6% of Vitalhub shares are owned by institutional investors. Comparatively, 47.0% of Dialogue Health Technologies shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by company insiders. Comparatively, 11.7% of Dialogue Health Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vitalhub has a net margin of 5.89% compared to Dialogue Health Technologies' net margin of -19.73%. Vitalhub's return on equity of 2.79% beat Dialogue Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.89% 2.79% 3.81%
Dialogue Health Technologies -19.73%-19.76%-10.01%

Vitalhub currently has a consensus price target of C$12.67, indicating a potential upside of 60.34%. Given Vitalhub's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vitalhub is more favorable than Dialogue Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
Dialogue Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Vitalhub beats Dialogue Health Technologies on 13 of the 15 factors compared between the two stocks.

How does Vitalhub compare to Reliq Health Technologies?

Reliq Health Technologies (CVE:RHT) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

In the previous week, Vitalhub had 3 more articles in the media than Reliq Health Technologies. MarketBeat recorded 3 mentions for Vitalhub and 0 mentions for Reliq Health Technologies. Reliq Health Technologies' average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
Reliq Health Technologies Neutral
Vitalhub Neutral

Vitalhub has a net margin of 5.89% compared to Reliq Health Technologies' net margin of -95.54%. Vitalhub's return on equity of 2.79% beat Reliq Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Reliq Health Technologies-95.54% -221.64% -5.30%
Vitalhub 5.89%2.79%3.81%

Reliq Health Technologies has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, Vitalhub has a beta of 0.914183, meaning that its share price is 9% less volatile than the broader market.

Vitalhub has higher revenue and earnings than Reliq Health Technologies. Reliq Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reliq Health TechnologiesN/AN/AN/A-C$0.02N/A
VitalhubC$127.08M3.93C$3.35MC$0.1265.83

2.8% of Reliq Health Technologies shares are held by institutional investors. Comparatively, 25.6% of Vitalhub shares are held by institutional investors. 1.8% of Reliq Health Technologies shares are held by company insiders. Comparatively, 18.6% of Vitalhub shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vitalhub has a consensus price target of C$12.67, indicating a potential upside of 60.34%. Given Vitalhub's stronger consensus rating and higher possible upside, analysts plainly believe Vitalhub is more favorable than Reliq Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Reliq Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Summary

Vitalhub beats Reliq Health Technologies on 13 of the 14 factors compared between the two stocks.

How does Vitalhub compare to DIAGNOS?

DIAGNOS (CVE:ADK) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Vitalhub has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIAGNOSC$65.48K689.62-C$3.81M-C$0.04N/A
VitalhubC$127.08M3.93C$3.35MC$0.1265.83

Vitalhub has a consensus target price of C$12.67, indicating a potential upside of 60.34%. Given Vitalhub's stronger consensus rating and higher probable upside, analysts clearly believe Vitalhub is more favorable than DIAGNOS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIAGNOS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

DIAGNOS has a beta of -0.141396, indicating that its stock price is 114% less volatile than the broader market. Comparatively, Vitalhub has a beta of 0.914183, indicating that its stock price is 9% less volatile than the broader market.

0.3% of DIAGNOS shares are owned by institutional investors. Comparatively, 25.6% of Vitalhub shares are owned by institutional investors. 16.8% of DIAGNOS shares are owned by insiders. Comparatively, 18.6% of Vitalhub shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Vitalhub had 3 more articles in the media than DIAGNOS. MarketBeat recorded 3 mentions for Vitalhub and 0 mentions for DIAGNOS. DIAGNOS's average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company Overall Sentiment
DIAGNOS Neutral
Vitalhub Neutral

Vitalhub has a net margin of 5.89% compared to DIAGNOS's net margin of -6,956.84%. DIAGNOS's return on equity of 11,659.44% beat Vitalhub's return on equity.

Company Net Margins Return on Equity Return on Assets
DIAGNOS-6,956.84% 11,659.44% -134.33%
Vitalhub 5.89%2.79%3.81%

Summary

Vitalhub beats DIAGNOS on 14 of the 16 factors compared between the two stocks.

How does Vitalhub compare to CloudMD Software & Services?

Vitalhub (TSE:VHI) and CloudMD Software & Services (CVE:DOC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Vitalhub has higher revenue and earnings than CloudMD Software & Services. CloudMD Software & Services is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$127.08M3.93C$3.35MC$0.1265.83
CloudMD Software & ServicesC$90.91M0.12-C$76.56M-C$0.23N/A

In the previous week, Vitalhub had 3 more articles in the media than CloudMD Software & Services. MarketBeat recorded 3 mentions for Vitalhub and 0 mentions for CloudMD Software & Services. Vitalhub's average media sentiment score of 0.00 equaled CloudMD Software & Services'average media sentiment score.

Company Overall Sentiment
Vitalhub Neutral
CloudMD Software & Services Neutral

Vitalhub has a net margin of 5.89% compared to CloudMD Software & Services' net margin of -91.12%. Vitalhub's return on equity of 2.79% beat CloudMD Software & Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.89% 2.79% 3.81%
CloudMD Software & Services -91.12%-102.91%-8.74%

Vitalhub presently has a consensus price target of C$12.67, suggesting a potential upside of 60.34%. Given Vitalhub's stronger consensus rating and higher probable upside, research analysts plainly believe Vitalhub is more favorable than CloudMD Software & Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
CloudMD Software & Services
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

25.6% of Vitalhub shares are held by institutional investors. Comparatively, 0.5% of CloudMD Software & Services shares are held by institutional investors. 18.6% of Vitalhub shares are held by insiders. Comparatively, 0.1% of CloudMD Software & Services shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Vitalhub has a beta of 0.914183, meaning that its stock price is 9% less volatile than the broader market. Comparatively, CloudMD Software & Services has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Summary

Vitalhub beats CloudMD Software & Services on 15 of the 16 factors compared between the two stocks.

How does Vitalhub compare to ZoomMed?

Vitalhub (TSE:VHI) and ZoomMed (CVE:ZMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Vitalhub currently has a consensus target price of C$12.67, indicating a potential upside of 60.34%. Given Vitalhub's stronger consensus rating and higher possible upside, equities analysts plainly believe Vitalhub is more favorable than ZoomMed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
ZoomMed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

25.6% of Vitalhub shares are held by institutional investors. 18.6% of Vitalhub shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Vitalhub had 3 more articles in the media than ZoomMed. MarketBeat recorded 3 mentions for Vitalhub and 0 mentions for ZoomMed. Vitalhub's average media sentiment score of 0.00 equaled ZoomMed'saverage media sentiment score.

Company Overall Sentiment
Vitalhub Neutral
ZoomMed Neutral

Vitalhub has a net margin of 5.89% compared to ZoomMed's net margin of 0.00%. Vitalhub's return on equity of 2.79% beat ZoomMed's return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.89% 2.79% 3.81%
ZoomMed N/A N/A N/A

Vitalhub has higher revenue and earnings than ZoomMed. ZoomMed is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$127.08M3.93C$3.35MC$0.1265.83
ZoomMedC$10K203.39-C$1.49M-C$0.01N/A

Summary

Vitalhub beats ZoomMed on 14 of the 15 factors compared between the two stocks.

Get Vitalhub News Delivered to You Automatically

Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VHI vs. The Competition

Export
MetricVitalhubHealthcare Technology IndustryHealthcare SectorTSE Exchange
Market CapC$499.75MC$1.62BC$7.06BC$12.54B
Dividend YieldN/A4.69%2.57%6.20%
P/E Ratio65.8324.17269.0630.69
Price / Sales3.9372.88592.579.75
Price / CashN/A30.7570.4882.29
Price / Book1.826.5212.914.60
Net IncomeC$3.35M-C$25.90MC$3.45BC$299.09M
7 Day Performance0.13%3.06%1.12%0.94%
1 Month Performance8.37%5.27%1.79%3.90%
1 Year Performance-37.94%-15.58%67.69%36.05%

Vitalhub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VHI
Vitalhub
2.1137 of 5 stars		C$7.90
-1.4%		C$12.67
+60.3%		-39.9%C$499.75MC$127.08M65.832,250
CARE
Dialogue Health Technologies
N/AN/AN/AN/AC$345.36MC$95.88MN/A730
RHT
Reliq Health Technologies
N/AC$0.22
flat		N/A+0.0%C$46.65MN/AN/A12,600
ADK
DIAGNOS
N/AC$0.30
+9.1%		N/A+42.9%C$36.12MC$65.48KN/AN/A
DOC
CloudMD Software & Services
N/AC$0.04
flat		N/A+0.0%C$10.66MC$90.91MN/A200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:VHI) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel